THE EMERGING ROLE OF BIOMARKERS IN mRCC:
Selecting Patients and Predicting Response to Treatment
FRIDAY, OCTOBER 23
12:00-1:30 p.m. EDT
Register now for this FREE, live CME webinar, featuring a discussion by renowned clinical experts of the growing body of research on predictive biomarkers in metastatic renal cancer.
During the live webinar, you’ll engage with the faculty through interactive patient case scenarios illustrating key clinical issues, dynamic panel discussions, and audience questions and answers.
Registrants will receive detailed program information, a case study, and polling questions via e-mail a few days before the event. Live opportunities for interactions included throughout the webinar.
Dr. Brian Shuch, UCLA
“Current Management of Localized RCC”
Dr. David Braun, DFCI
“Predicting Response to Immune Checkpoint Inhibition in RCC”
Dr. Hans Hammers, UTSW
“Putting It All Together: Future Role of Biomarkers in Predicting mRCC Treatment Response”
REGISTER USING THE FORM BELOW.
LOGIN INFORMATION PROVIDED VIA EMAIL PRIOR TO EVENT.
Supported by educational grants from Bristol Myers Squibb, Exelixis, and Merck & Co.